We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Admission Interim Review

1 Aug 2022 09:30

RNS Number : 4149U
Quadrise Fuels International PLC
01 August 2022
 

1 August 2022

 

Quadrise Fuels International plc

("Quadrise", or "Company")

 

Block Admission Interim Review

 

Quadrise (AIM:QFI), the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels, provides an update in relation to the Company's block admission arrangements (the "Block Admissions") in respect of new ordinary shares of 1 pence in the Company ("Ordinary Shares") which may be issued as a result of future exercises of existing warrants. The Block Admissions have been put in place to enable the Company to handle any future exercises of existing warrants in an efficient manner. 

 

Block Admission Interim Review

 

Pursuant to Rule 29 of, and Schedule Six to, the AIM Rules for Companies, the Company provides the following notification regarding its Block Admissions.

 

 

Name of the company:

 

 

Quadrise Fuels International plc

 

Name of scheme:

 

1. Warrants to subscribe for new Ordinary Shares at a price of 3.532 pence per new Ordinary Share at any time until expiry on 27 February 2022 issued by the Company in December 2019 (the "December 2019 Warrants"). The grant of the December 2019 Warrants was announced by the Company on 29 November 2019 in connection with a Morocco Representation Agreement announced on 6 March 2019.

 

2. Warrants to subscribe for new Ordinary Shares at a price of 5.78 pence per new Ordinary Share at any time until expiry on 27 September 2022 issued by the Company in September 2019 (the "September 2019 Warrants"). The grant of the September 2019 Warrants was first announced by the Company on 23 August 2019 in connection with a then announced issue of convertible securities by the Company. 

 

3.  Warrants to subscribe for new Ordinary Shares at a price of 7.48 pence per new Ordinary Share at any time until 6 September 2022 issued by the Company in September 2019 (the "September 2019 - Open Offer Warrants"). The grant of the September 2019 - Open Offer Warrants was announced by the Company on 30 September 2019 in connection with an open offer to existing Quadrise shareholders first announced on 9 September 2019. 

 

4. Warrants to subscribe for new Ordinary Shares at a price of 7.48 pence per new Ordinary Share at any time until expiry on 6 September 2022 issued by the Company in September 2019 (the "September 2019 - Subscription Warrants"). The grant of the September 2019 - Subscription Warrants was announced by the Company on 9 September 2019 in connection with a then announced subscription for new ordinary shares in the Company.

 

 

 

 

Period of return:

From:

1 February 2022

To:

31 July 2022

Number of unallotted securities not issued under the scheme(s) at the start of the period:

1:

2:

3:

4:

Total:

3,000,000

4,900,000

23,273,210

9,050,506

40,223,716

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1:

2:

3:

4:

Total:

0

0

0

0

0

Less:  Number of securities issued/allotted under scheme(s) during period:

1:

2:

3:

4:

Total:

0

0

0

0

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

 

1:

 

2:

 

3:

 

4:

 

Total:

 

3,000,000 warrants expired on 27 February 2022

 

4,900,000

 

23,273,210

 

9,050,506

 

37,223,716

 

Number and class of securities originally admitted and the date of admission:

 

1:

 

2:

 

3:

 

4:

 

Total:

 

 

3,000,000 - 5 August 2021

 

4,900,000 - 5 August 2021

 

23,277,519 - 5 August 2021

 

9,050,506 - 5 August 2021

 

40,228,025

Name of contact:

Ian Farrelly, Company Secretary

Telephone number of contact:

+44 (0) 20 7031 7321

 

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Jason Miles, Chief Executive Officer

+44 (0)20 7031 7321

David Scott, Head of Finance

Nominated Adviser

Cenkos Securities plc

Ben Jeynes

+44 (0)20 7397 8900

Katy Birkin

 

Broker

Shore Capital Stockbrokers Limited

Toby Gibbs

+44 (0)20 7408 4090

Fiona Conroy

Public & Investor Relations

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

 

 

 

Notes to Editors

QFI is the supplier of MSAR® and bioMSARTM emulsion technology and fuels, low-cost alternatives to heavy fuel oil (one of the world's largest fuel markets, comprising over 340 million tons per annum) in the global power generation, shipping, industrial and refining industries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRUARWRUOUWRRR
Date   Source Headline
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20218:00 amEQSEdison Investment Research Limited: Quadrise Fuels International (QFI): Cleaner fuel, cleaner planet
26th Nov 20213:30 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Statement
1st Nov 20215:00 pmRNSPosting of Annual Report and Notice of AGM
20th Oct 20215:45 pmRNSMorocco Travel Restrictions
5th Oct 20214:41 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSFinal Results, Directorate Change & Notice of AGM
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Sep 20217:00 amRNSUtah Project Update
20th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:30 pmRNSIssue of Share Options & Director/PDMR Dealing
2nd Sep 20214:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSPublication of bioMSAR Test Results
23rd Aug 20217:00 amRNSGreenfield Commercial Trial Agreement Extension
11th Aug 20217:00 amRNSUpdate on bioMSAR™ Testing
4th Aug 20217:00 amRNSUtah Project Update
30th Jul 20219:30 amRNSBlock Admissions
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
16th Jul 20211:15 pmRNSDirectorate Change
28th Jun 20217:00 amRNSUpdate on bioMSAR™ and MSAR® projects
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20219:24 amRNSIssue of Equity
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:50 pmRNSUpdate re Greenfield Commercial Trial Agreement
29th Mar 20217:00 amRNSInterim Results
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSResults of Open Offer
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResults of Placing and Open Offer Launch
1st Mar 20214:41 pmRNSProposed Placing and Open Offer
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSFinal Issue of Convertible Securities
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.